Radiopharmaceutical Sciences Institute (RSI)
Interdisciplinary research and educational programs in the radiopharmaceutical sciences have been expanding at MU for more than two decades. The Radiopharmaceutical Sciences Institute (RSI) was formed to serve as a catalyst for development of world-class interdisciplinary research and educational program at MU.
Its goals are to promulgate basic and applied research that advances a broad interdisciplinary research program in molecular imaging and targeted radiotherapy, to develop curricular innovations to enhance and broaden the educational and training opportunities for students and fellows, and to provide unique expertise to work collaboratively with MU departments and units with interests of incorporating radiopharmaceutical sciences-related research in their ongoing or future endeavors.
Research efforts by RSI investigators are primarily directed toward the design, formulation and study of novel radiolabeled biomolecular in vivo targeting agents for development as potential diagnostic and therapeutic radiopharmaceuticals. A major focus has been the development of cancer-specific radiopharmaceuticals.